Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Neuroscience|September 3, 2011
Slow phasic changes in nucleus accumbens dopamine release during fixed ratio acquisition: a microdialysis studyK N Segovia, M Correa, J D SalamonePharmacology, Biochemistry, and Behavior|March 30, 2010
The CB1 inverse agonist AM251, but not the CB1 antagonist AM4113, enhances retention of contextual fear conditioning in ratsK S Sink, K N Segovia, L E Collins, et al.Psychopharmacology|July 10, 2009
Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in ratsK S Sink, K N Segovia, E J Nunes, et al.Pharmacology, Biochemistry, and Behavior|August 18, 2010
The novel cannabinoid CB1 antagonist AM6545 suppresses food intake and food-reinforced behaviorP A Randall, V K Vemuri, K N Segovia, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 18, 2009
Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142K S Sink, K N Segovia, J Sink, et al.Neuroscience|January 26, 2010
Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptorsA M Farrar, K N Segovia, P A Randall, et al.Pageof 1